Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | RMD | ResMed Common Stock | 6.92K | Jul 1, 2022 | Direct | F1 |
Id | Content |
---|---|
F1 | Reflects beneficially owned shares as of July 1, 2022 when Ms. Blaise was appointed as an executive officer. |